CSIMarket Company Name, Ticker, Industry, else..


Amedisys Inc  (NASDAQ: AMED)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Amedisys Inc

AMED's Fundamental analysis



Looking into Amedisys Inc growth rates, revenue grew by 4.09 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 2026

Healthcare Facilities industry recorded growth of revenues by 3.64 %

Amedisys Inc's net income grew by 323.61 % in first quarter of 2025 year on year, above company average,

• More on AMED's Growth


Amedisys Inc
current PE on trailing twelve month basis is above Healthcare Facilities industry average.

Amedisys Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 19.72 in trailing twelve-month period.
Company
35.85
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.37.
Healthcare Facilities industry's Price to Sales ratio is at 1.06.


• More on AMED's Valuation
 
 Total Debt (Millions $) 371
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 124,826
 Net Income/Employee (TTM) $ 4,494
 Receivable Turnover (TTM) 7.45
 Tangible Book Value (Per Share $) -1.48

Amedisys Inc
current PE on trailing twelve month basis is above Healthcare Facilities industry average.

Amedisys Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 19.72 in trailing twelve-month period.
Company
35.85
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.37.
Healthcare Facilities industry's Price to Sales ratio is at 1.06.

Amedisys Inc Price to Book Ratio is at 2.6 lower than Industry Avg. of 213.1. and higher than S&P 500 Avg. of 0.01

• More on AMED's Valuation

•  Market Capitalization (Millions $) 3,237
•  Shares Outstanding (Millions) 33
•  Employees 19,000
•  Revenues (TTM) (Millions $) 2,372
•  Net Income (TTM) (Millions $) 85
•  Cash Flow (TTM) (Millions $) 164
•  Capital Exp. (TTM) (Millions $) -6
•  Total Debt (Millions $) 371
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 124,826
•  Net Income/Employee(TTM) $ 4,494
•  Receivable Turnover Ratio (TTM) 7.45
•  Tangible Book Value (Per Share $) -1.48

•  Market Capitalization (Millions $) 3,237
•  Shares Outstanding (Millions) 33
•  Employees 19,000
•  Revenues (TTM) (Millions $) 2,372
•  Net Income (TTM) (Millions $) 85
•  Cash Flow (TTM) (Millions $) 164
•  Capital Exp. (TTM) (Millions $) -6


    AMED's Profitability Comparisons
Amedisys Inc achieved increase in profitability, due to cost control. Operating Margin grew in first quarter of 2025 to 7.29 %.

Amedisys Inc net profit margin of 10.39 % is currently ranking no. 6 in Healthcare Facilities industry, ranking no. 96 in Healthcare sector and number 1220 in S&P 500.


Profitability by Segment
Total 10.39 %



  Ratio
•   Capital Ratio (MRQ) 1.29
•  Total Debt to Equity (MRQ) 0.3
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 1.15
•  Inventory Turnover Ratio (TTM) -



Amedisys Inc achieved increase in profitability, due to cost control. Operating Margin grew in first quarter of 2025 to 7.29 %.

Amedisys Inc net profit margin of 10.39 % is currently ranking no. 6 in Healthcare Facilities industry, ranking no. 96 in Healthcare sector and number 1220 in S&P 500.

• More on AMED's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com